Relationship of lymphocyte invasion and survival of brain tumor patients - PubMed (original) (raw)

Relationship of lymphocyte invasion and survival of brain tumor patients

W H Brooks et al. Ann Neurol. 1978 Sep.

Abstract

The length of survival of 149 patients harboring primary brain tumors was retrospectively correlated with the presence and location of lymphocytic infiltration. Mononuclear invasion of malignant gliomas confined to the perivascular spaces was the only histolgical finding that correlated significantly with survival. Patients with malignant gliomas containing perivascular infiltration live up to four months longer than those with no lymphocyte infiltration. The survival of patients with brain tumors who had lymphocyte invasion associated with areas of hemorrhage and necrosis beyond and separate from perivascular spaces was the same as far as for those with no lymphocyte involvement.

PubMed Disclaimer

Similar articles

• [Lymphocytic infiltration in cerebral gliomas].
  Bucciero A, Cerillo A, Quaglietta P, Villano M, Carraturo S, Vizioli L. Bucciero A, et al. Minerva Med. 1992 Jan-Feb;83(1-2):25-8. Minerva Med. 1992. PMID: 1312232 Italian.
• [Treatment modalities for malignant gliomas with reference to their pathophysiology].
  Kobayashi S, Takakura K. Kobayashi S, et al. Gan To Kagaku Ryoho. 1986 Jan;13(1):11-7. Gan To Kagaku Ryoho. 1986. PMID: 3942392 Japanese.
• [Immunohistological analysis of infiltrating lymphocyte subpopulations in gliomas and metastatic brain tumors].
  Saito T, Tanaka R, Kouno M, Takai N, Yoshida S, Hara N, Washiyama K, Sekiguchi K, Kumanishi T. Saito T, et al. No To Shinkei. 1987 Apr;39(4):339-45. No To Shinkei. 1987. PMID: 2439110 Japanese.
• [Prognostic factors in malignant gliomas].
  Ushio Y, Kochi M. Ushio Y, et al. Gan To Kagaku Ryoho. 1996 Apr;23(5):643-8. Gan To Kagaku Ryoho. 1996. PMID: 8678527 Review. Japanese.
• Biology and treatment of malignant glioma.
  Prados MD, Levin V. Prados MD, et al. Semin Oncol. 2000 Jun;27(3 Suppl 6):1-10. Semin Oncol. 2000. PMID: 10866344 Review.

Cited by

• A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
  Bullard DE, Thomas DG, Darling JL, Wikstrand CJ, Diengdoh JV, Barnard RO, Bodmer JG, Bigner DD. Bullard DE, et al. Br J Cancer. 1985 Feb;51(2):283-9. doi: 10.1038/bjc.1985.41. Br J Cancer. 1985. PMID: 3966985 Free PMC article. No abstract available.
• A feline model for experimental studies of peritumor brain edema.
  Bayens-Simmonds J, Boisvert DP, Castro ME, Johnson ES. Bayens-Simmonds J, et al. J Neurooncol. 1988 Dec;6(4):371-8. doi: 10.1007/BF00177435. J Neurooncol. 1988. PMID: 3221263
• The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw.
  Innocenti L, Ortenzi V, Scarpitta R, Montemurro N, Pasqualetti F, Asseri R, Lazzi S, Szumera-Cieckiewicz A, De Ieso K, Perrini P, Naccarato AG, Scatena C, Fanelli GN. Innocenti L, et al. Genes (Basel). 2023 Feb 15;14(2):501. doi: 10.3390/genes14020501. Genes (Basel). 2023. PMID: 36833428 Free PMC article.
• Molecular genetic analysis of giant cell glioblastomas.
  Meyer-Puttlitz B, Hayashi Y, Waha A, Rollbrocker B, Boström J, Wiestler OD, Louis DN, Reifenberger G, von Deimling A. Meyer-Puttlitz B, et al. Am J Pathol. 1997 Sep;151(3):853-7. Am J Pathol. 1997. PMID: 9284834 Free PMC article.
• DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival.
  Dejaegher J, Solie L, Hunin Z, Sciot R, Capper D, Siewert C, Van Cauter S, Wilms G, van Loon J, Ectors N, Fieuws S, Pfister SM, Van Gool SW, De Vleeschouwer S. Dejaegher J, et al. Neuro Oncol. 2021 Feb 25;23(2):240-250. doi: 10.1093/neuonc/noaa247. Neuro Oncol. 2021. PMID: 33130898 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Wiley